COMMUNIQUÉS West-GlobeNewswire

Vital Therapies Hosting Analyst R&D Day Today
24/05/2018
SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will host a live [...]
U.S. FDA Grants Fast Track Designation for Krystal Biotech’s KB103 for the Treatment of Dystrophic Epidermolysis Bullosa
24/05/2018
PITTSBURGH, May 24, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS ), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological diseases, [...]
Melinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
24/05/2018
NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Enrolment Completed in Cynata’s Phase 1 Clinical Trial of CYP-001 in GvHD
24/05/2018
MELBOURNE, Australia, May 24, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the final patient has been treated in [...]
United Rentals and Rahal Letterman Lanigan Racing Continue Support for Veterans Through SoldierStrong and Turns for Troops
24/05/2018
Every Lap IndyCar Drivers Graham Rahal, Oriol Servia, and 2017 Indy 500 Winner Takuma Sato Complete Benefits Veterans STAMFORD, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated [...]
Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma
24/05/2018
-- 1 st global Phase 3 trial focused on synovial sarcoma patients -- www.synovatestudy.com SEATTLE and SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy [...]
VBL Therapeutics to Present at Upcoming Conferences in June
24/05/2018
TEL AVIV, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Golden Leaf Holdings Hires Ryan Purdy as Vice President of Operations
24/05/2018
PORTLAND, Ore., May 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around [...]
Corium to Present at the Jefferies 2018 Global Healthcare Conference
24/05/2018
MENLO PARK, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D
24/05/2018
PLYMOUTH MEETING, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that it has bolstered its efforts to attract partnerships and collaborations and increase non-dilutive [...]
ATW Tech Announces an Increase in Its Revenues of 23% for Q1-2018 to Reach $3.4m
24/05/2018
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- ATW Tech (“AtmanCo” or the “Company”) (TSX-V: ATW ) announces its financial results for its 1st quarter ended March 31, 2018. For its first quarter of 2018, the Company [...]
ATW Tech annonce des revenus en hausse de 23% pour Q1-2018 pour atteindre 3,4m$
24/05/2018
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo » ou la « Société ») (TSX-V: ATW ) annonce aujourd'hui ses résultats pour son premier trimestre terminé le 31 mars 2018. Pour son premier trimestre 2018, la [...]
CareDx to Hold Press Conference at American Transplant Congress
24/05/2018
BRISBANE, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Adherium Announces Appointment of David Allinson as Chief Financial Officer
24/05/2018
SAN MATEO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced that David Allinson [...]
Progressive Care Begins Development of Proprietary Tele-pharmacy Software for Exclusive Use
24/05/2018
Leading Florida-Based Healthcare Services and Technology Company Expands its Kiosk Program in Florida MIAMI, May 24, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and [...]
Chembio Diagnostics Announces Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil
24/05/2018
MEDFORD, N.Y., May 24, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced the signing of a long-term agreement [...]
Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order
24/05/2018
$10 million annual Europe market anticipated with $1 million annual addressable sales potential from local Italy partner NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]
Tonix Pharmaceuticals Reports Preliminary Results from a Phase 1 Pivotal Multiple-Dose Bridging Pharmacokinetic (PK) Study of Tonmya® or TNX-102 SL
24/05/2018
Results from Preliminary PK Analyses Confirm the Applicability of the 505(b)(2) Regulatory Pathway for TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) New Drug Application Approval NEW YORK, May 24, 2018 (GLOBE [...]
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors
24/05/2018
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific [...]

Pages